Marta Villalba Montaner Instituciones de las que forman parte Investigador predoctoral Vall Hebron Institut de Recerca
Proyectos CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY RELATED MALIGNANCIES IP: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY Colaboradores: Marta Villalba Montaner, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY, Bárbara Tazón Vega, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY, Silvia Saumell Tutusaus, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY Entidad financiadora: Instituto de Salud Carlos III Financiación: 215380 Referencia: PI20/00881 Duración: 01/01/2021 - 31/12/2023